[HTML][HTML] Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections.
AJ Gehring, L Salimzadeh - Antiviral Research, 2024 - Elsevier
With the increasing momentum and success of monoclonal antibody therapy in conventional
medical practices, there is a revived emphasis on the development of monoclonal …
medical practices, there is a revived emphasis on the development of monoclonal …
Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections
AJ Gehring, L Salimzadeh - Antiviral research - pubmed.ncbi.nlm.nih.gov
With the increasing momentum and success of monoclonal antibody therapy in conventional
medical practices, there is a revived emphasis on the development of monoclonal …
medical practices, there is a revived emphasis on the development of monoclonal …
Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections.
AJ Gehring, L Salimzadeh - Antiviral Research, 2024 - europepmc.org
With the increasing momentum and success of monoclonal antibody therapy in conventional
medical practices, there is a revived emphasis on the development of monoclonal …
medical practices, there is a revived emphasis on the development of monoclonal …